Is Compounded Semaglutide Safe? A 2026 Buyer's Guide

The 2026 legal landscape

The FDA declared the semaglutide shortage resolved in early 2025. Once a drug is off the shortage list, compounders lose the exemption to make essentially-a-copy versions of the commercial drug. Legal compounded semaglutide now requires patient-specific medical justification: a documented allergy to a commercial inactive ingredient, a dose not commercially available, or a clinically indicated combination (like added B12).

Enforcement is real — state boards of pharmacy have sanctioned compounders producing generic copies, and Novo Nordisk has filed suits against multiple telehealth-affiliated pharmacies.

What legitimate compounding looks like

• Licensed 503A pharmacy (patient-specific) or 503B outsourcing facility (batch, under FDA oversight)
• API (active pharmaceutical ingredient) sourced from FDA-registered facilities
• Semaglutide base — not semaglutide sodium
• Individual patient prescription with documented medical rationale
• Certificate of Analysis available on request
• Cold-chain shipping
• Transparent about which pharmacy and where they source ingredients

Red flags

• Refuses to name the pharmacy
• Uses "semaglutide sodium" (unapproved salt form)
• Ships internationally or from unnamed foreign source
• No prescription required
• Advertises as "generic Ozempic" or "generic Wegovy"
• No temperature-controlled shipping
• Prices dramatically below the $150–$400/month legitimate range

How to vet a program

1. Ask which pharmacy fills your prescription. A legitimate program answers immediately. Vagueness is a red flag.
2. Check the pharmacy's license. Every state board of pharmacy has a public search. Look for active status, no disciplinary actions.
3. Ask 503A or 503B. Both can be legitimate; 503B has FDA-level manufacturing standards, 503A operates under state boards.
4. Ask about semaglutide base vs. sodium. The answer must be base. Sodium is an unapproved salt.
5. Ask about API source. Should be from an FDA-registered facility.
6. Ask for a Certificate of Analysis. Legitimate compounders provide potency and sterility test results.
7. Confirm cold-chain shipping. Peptides degrade quickly at high temperatures.
8. Check clinician credentials. Prescribing clinician should be licensed in your state.

The B12 combo question

Many compounded programs add cyanocobalamin (B12) to the formulation. The pharmacologic rationale is weak but adding B12 gives the pharmacy a legitimate medical-necessity justification for compounding. B12 is generally safe. It's not a red flag by itself.

What a Certificate of Analysis should include

• Semaglutide potency (should be within a defined range of label claim)
• Sterility test results
• Endotoxin test results
• Physical/chemical characterization
• Date of testing and analyst identification

Insurance and legal considerations

Compounded semaglutide is not FDA-approved and almost never covered by insurance. Legal risk to the patient is minimal, but be aware you're operating outside the FDA-approved supply chain and post-market safety monitoring.

Alternatives worth considering

• NovoCare direct Wegovy vials: ~$499/month (FDA-approved product)
• LillyDirect Zepbound vials: $349–$499/month (FDA-approved product)
• Insurance appeal for brand-name coverage

If you can access an FDA-approved product at a manageable price, that's the safest path. Compounded semaglutide is a reasonable option when brand access is unaffordable and the pharmacy checks out.

FAQ